Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The lamin-B receptor (LBR) encodes a dual-function inner nuclear membrane protein with both sterol C14-reductase activity and chromatin-anchoring roles. Pathogenic biallelic variants in LBR underlie a spectrum of phenotypes, including Pelger–Huët anomaly, Greenberg dysplasia, and the regressive type of spondylometaphyseal dysplasia (LBR-R-SMD). LBR-R-SMD presents prenatally with shortened and bowed tubular bones, metaphyseal irregularities, and a narrow thorax, often leading to perinatal lethality or severe skeletal malformations.
Autosomal recessive inheritance is established by a pseudodominant pedigree in which a fetus and his affected father both harbor homozygous c.1534C>T (p.Arg512Trp) (PMID:34467646), and a consanguineous Moroccan family with two affected fetuses carrying homozygous c.1379A>G (p.Asp460Gly) (PMID:30561119).
Across these two families, there are 3 probands and 1 additional affected relative demonstrating segregation of homozygous missense variants in LBR (PMID:34467646; PMID:30561119). The variant spectrum for LBR-R-SMD includes missense alleles within the sterol reductase domain such as c.1534C>T (p.Arg512Trp) and c.1379A>G (p.Asp460Gly).
Functional assays show that LBR missense mutations abolish sterol C14-reductase activity: patient-derived alleles fail to rescue C14-reductase deficient yeast and human cell models, confirming an enzymatic loss-of-function mechanism distinct from structural chromatin interactions (PMID:21327084). Carrier parents lack Pelger anomaly, indicating selective impairment of sterol reductase function.
Cellular and animal studies corroborate pathogenicity: LBR truncations and point mutants yield cholesterol auxotrophy in human cell lines, reduced protein stability at the nuclear envelope, and embryonic expression in skeletal precursors mirroring sites of dysplasia in mouse models (PMID:27336722).
No conflicting evidence has been reported for LBR in regressive spondylometaphyseal dysplasia. The genetic and experimental data integrate to support a loss-of-function mechanism via sterol reductase deficiency, accounting for the prenatal skeletal phenotype.
Key Take-home: Biallelic LBR variants cause autosomal recessive regressive spondylometaphyseal dysplasia through loss of sterol reductase activity, enabling accurate prenatal diagnosis and genetic counseling.
Gene–Disease AssociationModerate3 probands across two families, one multi-generational segregation, functional assays demonstrate sterol reductase loss [PMID:34467646],[PMID:30561119] Genetic EvidenceModerate3 probands with biallelic LBR missense variants segregating in two unrelated families Functional EvidenceModerateEnzymatic assays and cellular/animal models confirm loss of sterol reductase activity consistent with the human skeletal phenotype |